Identification of ciprofloxacin resistance by SimpleProbe, High Resolution Melt and Pyrosequencing nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis

Molecular and Cellular Probes

Volumn 24, Issue 3, 2010, Pages 154-160

  Loveless, Bonnie M ^a   Yermakova, Anastasiya ^b   Christensen, Deanna R ^a   Kondig, John P ^a   Heine, Henry S ^a   Wasieloski, Leonard P ^a   Kulesh, David A ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Antibiotic resistance; Ciprofloxacin; High Resolution Melt; Pyrosequence; SimpleProbe

Indexed keywords

ADENINE; CIPROFLOXACIN; CYTOSINE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; DNA TOPOISOMERASE IV; GUANINE; PROTEIN PARC; PROTEIN PARE; TYROSINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS ANTHRACIS; BASE PAIRING; BIOLOGICAL WARFARE; CONTROLLED STUDY; DNA MODIFICATION; ENZYME INHIBITION; FRANCISELLA TULARENSIS; GENE MUTATION; GENETIC ANALYSIS; INFECTION CONTROL; MOLECULAR PROBE; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PYROSEQUENCING; STRAIN IDENTIFICATION; YERSINIA PESTIS;

ANTI-INFECTIVE AGENTS; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FRANCISELLA TULARENSIS; MICROBIAL SENSITIVITY TESTS; MUTATION; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; YERSINIA PESTIS;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS; YERSINIA PESTIS;

EID: 77952237431     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2010.01.003     Document Type: Article

References (28)

1. Jernigan D.B., Raghunathan P.L., Bell B.P., Brechner R., Bresnitz E.A., Butler J.C., et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002, 8:1019-1028.
2. Traeger M.S., Wiersma S.T., Rosenstein N.E., Malecki J.M., Shepard C.W., Raghunathan P.L., et al. First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida. Emerg Infect Dis 2001, 2002(8):1029-1034.
3. Cieslak T., Christopher G.W. Medical management of potential biological casualties: a stepwise approach. Medical aspects of biological warfare 2007, 453. Office of the Surgeon General, United States Army; Borden Institute, Walter Reed Army Medical Center, Falls Church, VA; Washington, DC. Z.F. Dembek (Ed.).
4. Berger J.M. Type II DNA topoisomerases. Curr Opin Struct Biol 1998, 8:26-32.
5. Leo E., Gould K.A., Pan X.S., Capranico G., Sanderson M.R., Palumbo M., et al. Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site. J Biol Chem 2005, 280:14252-14263.
6. Wolfson J.S., Hooper D.C. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 1989, 2:378-424.
7. Hooper D.C. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001, 32(Suppl. 1):S9-S15.
8. Eaves D.J., Randall L., Gray D.T., Buckley A., Woodward M.J., White A.P., et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother 2004, 48:4012-4015.
9. Hooper D.C., Wolfson J.S., Ng E.Y., Swartz M.N. Mechanisms of action of and resistance to ciprofloxacin. Am J Med 1987, 82:12-20.
10. Price L.B., Vogler A., Pearson T., Busch J.D., Schupp J.M., Keim P. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother 2003, 47:2362-2365.
11. Lindler L.E., Fan W. Development of a 5' nuclease assay to detect ciprofloxacin resistant isolates of the biowarfare agent Yersinia pestis. Mol Cell Probes 2003, 17:41-47.
12. Liew M., Pryor R., Palais R., Meadows C., Erali M., Lyon E., et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 2004, 50:1156-1164.
13. Lindler L.E., Fan W., Jahan N. Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler. J Clin Microbiol 2001, 39:3649-3655.
14. Hurtle W., Lindler L., Fan W., Shoemaker D., Henchal E., Norwood D. Detection and identification of ciprofloxacin-resistant Yersinia pestis by denaturing high-performance liquid chromatography. J Clin Microbiol 2003, 41:3273-3283.
15. La S.B., Elkarkouri K., Li W., Wahab T., Fournous G., Rolain J.M., et al. Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm. Genome Res 2008, 18:742-750.
16. Shen L.L., Kohlbrenner W.E., Weigl D., Baranowski J. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J Biol Chem 1989, 264:2973-2978.
17. Cullen M.E., Wyke A.W., Kuroda R., Fisher L.M. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob Agents Chemother 1989, 33:886-894.
18. Yoshida H., Bogaki M., Nakamura M., Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990, 34:1271-1272.
19. Morais Cabral J.H., Jackson A.P., Smith C.V., Shikotra N., Maxwell A., Liddington R.C. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 1997, 388:903-906.
20. Horowitz D.S., Wang J.C. Mapping the active site tyrosine of Escherichia coli DNA gyrase. J Biol Chem 1987, 262:5339-5344.
21. Hooper D.C. Mode of action of fluoroquinolones. Drugs 1999, 58(Suppl. 2):6-10.
22. Piddock L.J. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 1999, 58(Suppl. 2):11-18.
23. Drlica K., Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997, 61:377-392.
24. Ferrero L., Cameron B., Crouzet J. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother 1995, 39:1554-1558.
25. Pan X.S., Ambler J., Mehtar S., Fisher L.M. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother 1996, 40:2321-2326.
26. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009, 22:664-689.
27. Gundry C.N., Vandersteen J.G., Reed G.H., Pryor R.J., Chen J., Wittwer C.T. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. Clin Chem 2003, 49:396-406.
28. Wittwer C.T., Reed G.H., Gundry C.N., Vandersteen J.G., Pryor R.J. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003, 49:853-860.